CALGARY, Alberta, March 02, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX; OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to […]
SALT LAKE CITY, UT, Feb. 26, 2021 (GLOBE NEWSWIRE) — Today, Mr. Joseph LaStella, President of Green Star Products, Inc. (USOTC: GSPI) stated, “The Company has enough early votes to close the COVID-19 contract with BTR […]
Identified multiple hydrothermal system centers in and surrounding the Project area, representing a possible “cluster” scenario. […]
Completion of research and development phase for HaluGen’s Psychedelics Genetic Test […]
Science in Action confirmed that they have received ethics approval for an in-vivo non-GLP toxicology study of N, N Dimethyltryptamine (DMT). […]
Following the Meeting, Mr. Adrian Smith, Mr. Collin Kim, Mr. Ken Chung, Mr. Kosta Tsoutsis and Mr. Mike Collins will serve on the board of directors. […]
The Company is participating in the BIO CEO and Investor Digital Conference to be held virtually February 16-18, 2021. […]
Vancouver, British Columbia–(Newsfile Corp. – February 4, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTC PINK: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is […]
PurCann, a subsidiary of SiliCycle, is recognized for its unique expertise in the Extraction-Purification and commercialization of cannabinoids. […]
Mr. Lynam to Oversee Clinical Studies of Sigyn Therapy™ to Treat Life-Threatening Inflammatory Conditions […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com